Endothelial-Mesenchymal Transition in Regenerative Medicine
Author
Source
Issue
Vol. 2016, Issue 2016 (31 Dec. 2015), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2016-04-07
Country of Publication
Egypt
No. of Pages
7
Abstract EN
Endothelial-mesenchymal transition (EndMT) is a fundamental cellular mechanism that regulates embryonic development and diseases such as cancer and fibrosis.
Recent developments in biomedical research have shown remarkable potential to harness the EndMT process for tissue engineering and regeneration.
As an alternative to traditional or artificial stem cell therapies, EndMT may represent a safe method for engineering new tissues to treat degenerative diseases by mimicking a process that occurs in nature.
This review discusses the signaling mechanisms and therapeutic inhibitors of EndMT, as well as the role of EndMT in development, disease, acquiring stem cell properties and generating connective tissues, and its potential as a novel mechanism for tissue regeneration.
American Psychological Association (APA)
Medici, Damian. 2016. Endothelial-Mesenchymal Transition in Regenerative Medicine. Stem Cells International،Vol. 2016, no. 2016, pp.1-7.
https://search.emarefa.net/detail/BIM-1117017
Modern Language Association (MLA)
Medici, Damian. Endothelial-Mesenchymal Transition in Regenerative Medicine. Stem Cells International Vol. 2016, no. 2016 (2015), pp.1-7.
https://search.emarefa.net/detail/BIM-1117017
American Medical Association (AMA)
Medici, Damian. Endothelial-Mesenchymal Transition in Regenerative Medicine. Stem Cells International. 2016. Vol. 2016, no. 2016, pp.1-7.
https://search.emarefa.net/detail/BIM-1117017
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1117017